C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/18 (2006.01) C40B 30/00 (2006.01) G01N 33/53 (2006.01) G01N 33/543 (2006.01) G01N 33/68 (2006.01) G01N 33/82 (2006.01) C40B 40/10 (2006.01) G01N 27/00 (2006.01)
Patent
CA 2668640
Low molecular weight (LMW) peptides have been discovered that are indicative of neurological conditions, such as Alzheimer's Disease (AD), cognitive impairment and brain microhemmorhages. Evaluating patient samples for the presence of such LMW peptides is an effective means of detecting neurological conditions and monitoring the progression of the disease. The LMW peptides are particularly useful in detecting neurological conditions during the early stages without invasive procedures.
On a constaté que des peptides à bas poids moléculaire (LMW) étaient évocateurs de troubles neurologiques tels que la maladie d'Alzheimer, le handicap cognitif ou les micro-hémorragies cérébrales. L'évaluation d'échantillons prélevés sur des patients dans le but de rechercher la présence de tels peptides constitue un moyen efficace de détection de troubles neurologiques et de surveillance de la progression de ces troubles. Les peptides à bas poids moléculaire conviennent particulièrement pour la détection précoce de troubles neurologiques sans recours à des techniques effractives.
Espina Virginia
Kirsch Wolff
Liotta Lance
Magaki Shino
Mueller Claudius
George Mason Intellectual Properties Inc.
Goudreau Gage Dubuc
Loma Linda University
LandOfFree
Biomarkers for neurological conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for neurological conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for neurological conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361481